Targeted gene therapies are highly effective at stopping cancers, but the very abundance of the treatments, plus cost and ...
The typical price for a newly approved prescription drug has surpassed $250,000, a new study shows, reflecting rising costs for insurers, patients.
Watch out, metastatic ER+/HER2- breast cancer. There’s a new targeted agent in town. On Tuesday, the U.S. Food and Drug Administration approved the drug gedatolisib, a multi-targeted kinase inhibitor ...
Add Yahoo as a preferred source to see more of our stories on Google. This photo provided by Revolution Medicines on Wednesday, Aug. 26, 2026 shows packaging for the new pancreatic cancer drug, ...
Add Yahoo as a preferred source to see more of our stories on Google. The Food and Drug Administration on Wednesday approved a groundbreaking new drug for advanced pancreatic cancer, offering U.S.
Could a new drug that makes fat cells self-destruct be the next big GLP-1? CBL-514 targets fat cells, and a new study shows that it was effective in slimming down participants’ waistlines. Early data ...
The Food and Drug Administration on Wednesday rubber-stamped a new drug to treat pancreatic cancer and substantially extend the lives of patients. The drug, daraxonrasib, is produced by Revolution ...
The first-of-its-kind drug offers a reprieve for people who live with the debilitating sleep disorder. By Carolyn Y. Johnson Many people have a cartoonish idea of narcolepsy, perhaps picturing someone ...
An update to this study of ICER has been published here, thanks to conversation with and insight from Mitchell Stein, policy and communications director at ICER, who clarified the differences between ...
Please provide your email address to receive an email when new articles are posted on . The new drug application included data from the phase 3 ADVANCES OUTCOMES trial. The Prescription Drug User Fee ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results